Latest Medical statistics Stories
SAN FRANCISCO, May 22, 2014 /PRNewswire/ -- PULSE enables highly customized IRT trial design while maintaining endpoint's signature 30-Day delivery timeline
SAN FRANCISCO, May 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, announced that Ivan Gergel, M.D., will
Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May
Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR),
CLEVELAND, May 6, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics today announced that top-line interim data from its ongoing Phase II STOP-HF study will be presented in a late-breaking
ACRP Innovation Award is Latest for CRO Health Decisions DURHAM, N.C., April 30, 2014 /PRNewswire-iReach/ -- Health
Theorem Selects iMedNet(TM) EDC as Their eClinical Solution of Choice for Medical Device & Diagnostics Research Initiatives MINNETONKA, Minn., April 29, 2014 /PRNewswire/ --
Latest Data Sweep from Large Subgroup of Patients Shows a Strong 50% Improvement in Overall Survival for ThermoDox® LAWRENCEVILLE, N.J., April 24, 2014 /PRNewswire/ -- Celsion Corporation
Verified Clinical Trials is proud to announce their presence at the 2014 Annual DIA meeting in San Diego, California.
Clinical Results Open Significant Market Opportunity for BioElectronics Corp. FREDERICK, Md., April 16, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.